New classes of antibacterial oxazolidinones with C-5, methylene O-linked heterocyclic side chains

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 23, 2003, Pages 4179-4186

  Gravestock, Michael B ^a   Acton, David G ^a   Betts, Michael J ^a   Dennis, Michael ^a   Hatter, Glenn ^a   McGregor, Alexandra ^a   Swain, Michael L ^a   Wilson, R Geoffrey ^a   Woods, Lisa ^a   Wookey, Alan ^a  

^a ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; ISOXAZOLE DERIVATIVE; METHYL GROUP; OXAZOLIDINONE DERIVATIVE; POSIZOLID; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; ENTEROCOCCUS FAECALIS; NONHUMAN; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PYOGENES; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

EID: 10744219579     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2003.07.033     Document Type: Article

References (26)

1. Norrby R. Exp. Opin. Pharmcother. 2:2001;2932.
2. Tomasz A. N. Engl J. Med. 330:1994;1247.
3. Spera R.V. Jr., Farber B.F. Drugs. 48:1994;678.
4. Smith T.L., Pearson M.L., Wilcox K.R., Cruz C., Lancaster M.V., Robinson-Dunn B., Tenover F.C., Zervos M.J., Band J.D., White E., Jarvis W.R. Engl. J. Med. 340:1999;493.
5. Brumfitt W., Hamilton-Miller J.M.T. Drugs Exp. Clin. Res. XX:1994;215.
6. Gregory, W. A. US Patent 4,705,799, 1987.
7. Slee A.M., Wuonola M.A., McRipley R.J., Zajac I., Zawada M.J., Bartholomew P.T., Gregory W.A., Forbes M. Antimicrob. Agents Chemother. 31:1987;1791.
8. Eustice D.C., Feldman P.A., Zajac I., Slee A.M. Antimicrob. Agents Chemother. 32:1988;1218.
9. Hutchinson, D. K.; Brickner, S. J.; Barbachyn, M. R.; Gammill, R. B.; Patel, M. V. PCT WO 93/23384, 1993.
10. Riedl, B.; Häbich, D.; Stolle, A.; Wild, H.; Endermann, R.; Bremm, K.; Kroll, H.-P.; Labischinski, H.; Schaller, K.; Werling, H.-O. EP 694543, 1996.
11. Betts, M. J.; Darbyshire, C. J. PCT WO 98/01446, 1998.
12. Brickner S.J., Hutchinson D.K., Barbachyn M.R., Manninen P.R., Ulanowicz D.A., Garmon S.A., Grega K.C., Hendges S.K., Toops D.S., Ford C.W., Zurenko G.E. J. Med. Chem. 39:1996;673.
13. Xiong L., Kloss P., Douthwaite S., Andersen N.M., Swaney S., Shinabarger D.L., Makin A.S. J. Bacteriol. 182:2000;5325.
14. Kloss P., Xiong L., Shinabarger D.L., Mankin A.S. J. Mol. Biol. 294:1999;93.
15. Aoki H., Ke L., Poppe S.M., Poel T.J., Weaver E.A., Gadwood R.C., Thomas R.C., Shinabarger D.L., Gonaza M.C. Antimicrob. Agents Chemother. 46:2002;1080.
16. Gonzales R.D., Schreckenberger P.C., Graham M.B., Kelkar S., DenBesten K., Quinn J.P. Lancet. 357:2001;1179.
17. Tsiodras S., Gold H.S., Sakoulas G., Eliopoulas G.M., Wennerstein C., Venkaturaman L., Moellering R.C. Jr., Ferro M.J. Lancet. 358:2001;207.
18. A preliminary description of this work was presented at 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Francisco, Sept. 26-29, 1999; American Society for Microbiology: Washington; Poster F-1825.
19. Gregory W.A., Brittelli D.R., Wang C.-L.J., Wuonola M.A., McRipley R.J., Eustice D.C.R.J., Eberly V.S., Bartholomew P.T., Slee A.M., Forbes M. J. Med. Chem. 32:1989;1673.
20. (a) Gregory W.A., Brittelli D.R., Wang C.-L.J., Kezar H.S., Carlson R.K., Park C.-H., Corless P.F., Miller S.J., Rajagopalan P., Wuonola M.A., McRipley R.J., Eberly V.S., Slee A.M., Forbes M. J. Med. Chem. 33:1990;2569
21. (b) Park C.-H., Brittelli D.R., Wang C.L.-J., Marsh F.D., Gregory W.A., Wuonola M.A., McRipley R.J., Eberly V.S., Slee A.M., Forbes M. J. Med. Chem. 35:1992;1156.
22. Hester, J. B.; Nidy, E. G.; Perricone, S. C.; Poel, T.-J. PCT WO 98/54161, 1998.
23. Gravestock M. B.; Mulhoney-Flynn, A.; Feron L. J. Unpublished observations.
24. Gravestock, M. B. PCT WO 97/30995, 1997.
25. Gravestock M. B.; Roberts, D. A.; Betts, M. J.; Mills, S. D. M.; Hatter, G. PCT WO 00/21960, 2000.
26. Gravestock M. B. Griffen, D.; Betts, M. J.; Mathews, PCT WO 01/81350, 2001.